Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,952.00
Bid: 4,952.00
Ask: 4,954.00
Change: 4.00 (0.08%)
Spread: 2.00 (0.04%)
Open: 4,982.00
High: 4,988.00
Low: 4,884.00
Prev. Close: 4,948.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

11 Dec 2020 07:00

RNS Number : 3038I
Intertek Group PLC
11 December 2020
 

11 December 2020, London

Intertek Group plc ('Intertek' or the 'Group')

Appointment of a new Chairman and directorate changes

Intertek Group plc announces that Andrew Martin will succeed Sir David Reid as Chairman of the Board on 1 January 2021. Sir David will retire as Chairman and non-executive director with effect from 31 December 2020 after serving on Intertek's Board for nine years.

Andrew Martin joined the Board of Intertek as an independent non-executive director on 26 May 2016. Andrew is currently non-excutive chairman of Hays plc and and a non-executive director of the John Lewis Partnership, and was previously a non-executive director of easyjet plc. Andrew is a qualified accountant and an associate of the Chartered Institute of Taxation.

Upon being appointed Chairman, Andrew Martin will chair the Nomination Committee, step down as Chair of the Audit Committee and cease to be a member of the Remuneration Committee. Jean-Michel Valette will be appointed Chair of the Audit Committee with effect from 1 January 2021.

Sir David Reid, Chairman of Intertek, commented: 

"I am delighted to announce that Andy will succeed me as Chairman of Intertek in the New Year. Andy has substantial board and wide-ranging business experience from an impressive executive and non-executive career covering a number of large international organisations and has extensive knowledge of Intertek.

I am honoured to have served as Intertek Chairman for the past nine years and to have been part of the impressive growth and sustainable value creation for all stakeholders, and I look forward to following the Company's future success in the years ahead."

Andrew Martin said:

"I am absolutely delighted to be taking over the role as Chair of the Board from David and to be working with such a strong leadership team led by our Chief Executive, André Lacroix, to continue to build on the growth and success of the business."

Graham Allan, Intertek's Senior Independent Director, said:

"I am delighted that the comprehensive process of finding a successor to David has now resulted in Andy's appointment. Andy's impressive executive and non-executive experience make him ideally positioned to carry on David's great work."

André Lacroix, Intertek Chief Executive said:

"I would like to thank David for the significant contribution he has made to Intertek's development and growth during his tenure with our Board. We will miss his wise counsel and experience and wish him every success and enjoyment for his future retirement. I am looking forward to working with Andy and Jean-Michel in their new roles, together with our non-executive director colleagues, to support the quality, safety and sustainability agenda of our clients with our Total Quality Assurance industry leading solutions."

Additional information

 

In accordance with section 430 (2B) of the Companies Act 2006, Intertek confirms that no remuneration payment will be made by Intertek to Sir David Reid after he ceases to be Chairman and non-executive director of the Company, nor will any payment for loss of office be made.

 

-ENDS-

Contacts

For further information, please contact:

Denis Moreau, Investor Relations

Telephone: +44 (0) 20 7396 3415 investor@intertek.com

 

Jonathon Brill, FTI Consulting

Telephone: +44 (0) 20 3727 1000  scintertek@fticonsulting.com

 

 

 

Intertek is a leading Total Quality Assurance provider to industries worldwide. Our network of more than 1,000 laboratories and offices and over 44,000 people in more than 100 countries, delivers innovative and bespoke Assurance, Testing, Inspection and Certification solutions for our customers' operations and supply chains.

Intertek Total Quality Assurance expertise, delivered consistently, with precision, pace and passion, enabling our customers to power ahead safely.

intertek.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABCBDDRSBDGGG
Date   Source Headline
22nd Mar 20249:00 amRNSAnnual Financial Report
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
13th Mar 20241:00 pmRNSDirector/PDMR Shareholding
5th Mar 20247:00 amRNSFinal Results
4th Mar 20247:00 amRNSAcquisition
1st Mar 20241:00 pmRNSDirectorate Change
28th Feb 20241:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSTrading Statement
22nd Nov 20231:00 pmRNSBlock listing Interim Review
14th Sep 20231:00 pmRNSDirector Declaration
24th Aug 20237:00 amRNSAcquisition
28th Jul 20237:00 amRNSHalf-year Report
12th Jul 202310:00 amRNSDirectorate Change
7th Jun 20231:00 pmRNSDirector/PDMR Shareholding
31st May 20231:00 pmRNSDirector/PDMR Shareholding
30th May 20233:00 pmRNSHolding(s) in Company
30th May 20231:00 pmRNSBlock listing Interim Review
24th May 202311:00 amRNSResult of AGM
24th May 20237:00 amRNSTrading Statement
3rd May 20237:00 amRNSCapital Markets Event
27th Apr 20234:00 pmRNSDirector Declaration
26th Apr 20234:30 pmRNSDirector Declaration
20th Apr 20234:00 pmRNSDirector Declaration
3rd Apr 20237:00 amRNSAcquisition
24th Mar 20239:00 amRNSNotice of 2023 AGM
21st Mar 20239:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSDirectorate Change
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSFinal Results
23rd Dec 202210:00 amRNSDirectorate Change
13th Dec 202211:00 amRNSDirector Declaration
12th Dec 20221:00 pmRNSDirector Declaration
24th Nov 20227:00 amRNSTrading Statement
21st Nov 20221:00 pmRNSBlock listing Interim Review
2nd Aug 20229:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:01 amRNSAcquisition
29th Jul 20227:00 amRNSHalf-year Report
21st Jun 20221:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSDirectorate Change
25th May 202211:00 amRNSResult of AGM
25th May 20227:00 amRNSTrading Statement
23rd May 20221:00 pmRNSBlock listing Interim Review
4th Apr 20223:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
18th Mar 20229:00 amRNSAnnual Financial Report
14th Mar 20221:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.